These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1450632)

  • 1. Towards understanding the pathophysiology of chronic rejection.
    Häyry P; Mennander A; Yilmaz S; Ustinov J; Räisänen A; Miettinen A; Lautenschlager I; Lemström K; Bruggeman CA; Paavonen T
    Clin Investig; 1992 Sep; 70(9):780-90. PubMed ID: 1450632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
    Mennander A; Räisänen A; Paavonen T; Häyry P
    Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis.
    Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T
    FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
    Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.
    Mennander A; Paavonen T; Häyry P
    Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells in acute and chronic rejection of rat cardiac allografts--a major source of basic fibroblast growth factor.
    Koskinen PK; Kovanen PT; Lindstedt KA; Lemström KB
    Transplantation; 2001 Jun; 71(12):1741-7. PubMed ID: 11455252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.
    Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis.
    Mennander A; Tiisala S; Paavonen T; Halttunen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):173-9. PubMed ID: 1958283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft rejection: an update.
    Häyry P; Yilmaz S
    Transplant Proc; 1994 Dec; 26(6):3159-60. PubMed ID: 7998102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of allograft arteriosclerosis after retransplantation to donor strain.
    Mennander A; Häyry P
    Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
    Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
    Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of allograft arteriosclerosis.
    Häyry P; Paavonen T; Mennander A; Ustinov J; Räisänen A; Lemström K
    Transplant Proc; 1993 Apr; 25(2):2070. PubMed ID: 8470274
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
    Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
    Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
    Li W; Iyer S; Lu L; Buelow R; Fung JJ; Rao AS; Woo J; Qian S
    Transpl Int; 2003 Dec; 16(12):849-56. PubMed ID: 12942166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
    Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
    Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
    Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
    [No Abstract]   [Full Text] [Related]  

  • 19. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of chronic renal allograft rejection.
    Lemström K; Koskinen P; Häyry P
    Kidney Int Suppl; 1995 Dec; 52():S2-10. PubMed ID: 8587277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.